Oncologists are having a problem in the past – the lack of communication between each other made it impossible to compile all reports about cancer. Thankfully, two concerned oncologists from Roswell Park Cancer Institute had a brilliant idea – they wanted to create a platform where oncologists can meet virtually. Mikhail Blagosklonny and Andrei V. Gudkov soon decided that what the oncologists need is an online space where they can speak with each other, and send necessary files to be published later on. They coined the term Oncotarget for the online medical journal that they created, and they made it live in 2010. The online medical journal was widely praised by the people from the scientific community, stating that the idea was brilliant and that it can save a lot of people in the future. Mikhail Blagosklonny and Andrei V. Gudkov stated that what the oncologists around the world need are sharing the information that they have on hand to expand the knowledge of their colleagues about cancer. Follow Oncotarget on Twitter.
The online medical journal has been operating for more than seven years now. The first articles which were published in 2010 were made by Mikhail Blagosklonny and Andrei V. Gudkov themselves, who served as the editors in chief of Oncotarget. They managed to get additional write-ups from other scientists who are working with Oncotarget as contributors. There is a lot of information that can be gained from reading a single journal coming from Oncotarget, and the people around the world are giving the online medical journal a positive review and a good reputation for allowing the public to see scholarly articles written by some of the best scientists around the world. Download output styles at Endnote.com
Recently, Oncotarget even sent some of their contributors and affiliated scientists to a global conference in Singapore. All of the beneficiaries of the travel incentive are biomedical researchers from different nations. They are planning to attend the Frontiers of Cancer Science 2017 and learn more information about the disease and the latest methods on how to treat the patients who have cancer. The information will also be reviewed later on by the representatives chose by Oncotarget, so that it can be published on their website.
The success of Oncotarget has prompted us to launch sections beyond oncology – https://t.co/ccRO4O68Oj
— Oncotarget (@OncotargetJrnl) December 14, 2017